- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting telomerase for cancer therapy
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-30
DOI
10.1038/s41388-020-01405-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple cancer pathways regulate telomere protection
- (2019) Leire Bejarano et al. EMBO Molecular Medicine
- Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer
- (2019) Young Shin Song et al. ENDOCRINE-RELATED CANCER
- The ETS Factor ETV5 Activates the Mutant TERT Promoter in Thyroid Cancer
- (2019) Martyn Bullock et al. THYROID
- TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma
- (2019) Lisa Gabler et al. Acta Neuropathologica Communications
- Telomerase promotes formation of a telomere protective complex in cancer cells
- (2019) Omesha N. Perera et al. Science Advances
- Genomic and Transcriptomic Analysis Reveals Incremental Disruption of Key Signaling Pathways during Melanoma Evolution
- (2018) A. Hunter Shain et al. CANCER CELL
- Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma
- (2018) Joydeep Mukherjee et al. CANCER RESEARCH
- An Activity Switch in Human Telomerase Based on RNA Conformation and Shaped by TCAB1
- (2018) Lu Chen et al. CELL
- Structure of Telomerase with Telomeric DNA
- (2018) Jiansen Jiang et al. CELL
- Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
- (2018) Thomas J. Mitchell et al. CELL
- Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
- (2018) Gao Zhang et al. CLINICAL CANCER RESEARCH
- Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors
- (2018) Satarupa Sengupta et al. MOLECULAR CANCER THERAPEUTICS
- Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT
- (2018) Elizabeth K. Duperret et al. MOLECULAR THERAPY
- Cryo-EM structure of substrate-bound human telomerase holoenzyme
- (2018) Thi Hoang Duong Nguyen et al. NATURE
- TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma
- (2018) Sabine Spiegl-Kreinecker et al. NEURO-ONCOLOGY
- Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma
- (2018) Patricia Reyes-Uribe et al. ONCOGENE
- Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
- (2018) Rengyun Liu et al. Nature Communications
- Modular ssDNA binding and inhibition of telomerase activity by designer PPR proteins
- (2018) Henrik Spåhr et al. Nature Communications
- Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner
- (2018) Xuehuo Zeng et al. Cell Reports
- Telomerase-Mediated Strategy for Overcoming Non–Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
- (2018) Ilgen Mender et al. NEOPLASIA
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
- (2018) Andrew Mancini et al. CANCER CELL
- GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression
- (2018) Xiaotian Yuan et al. ONCOGENE
- Solution structures of multiple G-quadruplex complexes induced by a platinum(II)-based tripod reveal dynamic binding
- (2018) Wenting Liu et al. Nature Communications
- NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer
- (2018) Andrew T. Ludlow et al. Nature Communications
- MYC drives overexpression of telomerase RNA (hTR /TERC ) in prostate cancer
- (2017) Javier A Baena-Del Valle et al. JOURNAL OF PATHOLOGY
- Whole-genome landscapes of major melanoma subtypes
- (2017) Nicholas K. Hayward et al. NATURE
- Systematic analysis of telomere length and somatic alterations in 31 cancer types
- (2017) Floris P Barthel et al. NATURE GENETICS
- Mutations in the promoter of the telomerase geneTERTcontribute to tumorigenesis by a two-step mechanism
- (2017) Kunitoshi Chiba et al. SCIENCE
- A method for measuring the distribution of the shortest telomeres in cells and tissues
- (2017) Tsung-Po Lai et al. Nature Communications
- Telomere Length and Risk of Cancer and Non-neoplastic Diseases: Is Survivin the Ariadne's Thread?—Reply
- (2017) Philip C. Haycock et al. JAMA Oncology
- Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies
- (2016) S. Sandri et al. CANCER RESEARCH
- Shelterin Protects Chromosome Ends by Compacting Telomeric Chromatin
- (2016) Jigar N. Bandaria et al. CELL
- Epidemiology, multistage models, and short-term mutagenicity tests
- (2016) Richard Peto INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Feeling Nature’s PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS)
- (2016) Jonathan B. Baell JOURNAL OF NATURAL PRODUCTS
- A second chance for telomerase reverse transcriptase in anticancer immunotherapy
- (2016) Maurizio Zanetti Nature Reviews Clinical Oncology
- Activation of mutantTERTpromoter by RAS-ERK signaling is a key step in malignant progression of BRAF-mutant human melanomas
- (2016) Yinghui Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations
- (2016) Matthew M. Makowski et al. PROTEOMICS
- Long-Range Chromatin Interactions Drive Mutant TERT Promoter Activation
- (2016) S. C. Ak nc lar et al. Cancer Discovery
- TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation
- (2016) Andrelou F. Vallarelli et al. Oncotarget
- Regulation of the Human Telomerase Gene TERT by Telomere Position Effect—Over Long Distances (TPE-OLD): Implications for Aging and Cancer
- (2016) Wanil Kim et al. PLOS BIOLOGY
- Loss of ATRX Suppresses Resolution of Telomere Cohesion to Control Recombination in ALT Cancer Cells
- (2015) Mahesh Ramamoorthy et al. CANCER CELL
- Therapeutic inhibition of TRF1 impairs the growth of p53-deficient K-RasG12V-induced lung cancer by induction of telomeric DNA damage
- (2015) M. Garcia-Beccaria et al. EMBO Molecular Medicine
- Mutation of theTERTpromoter, switch to active chromatin, and monoallelicTERTexpression in multiple cancers
- (2015) Josh Lewis Stern et al. GENES & DEVELOPMENT
- Human telomerase: biogenesis, trafficking, recruitment, and activation
- (2015) Jens C. Schmidt et al. GENES & DEVELOPMENT
- Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study
- (2015) Chenan Zhang et al. HUMAN MOLECULAR GENETICS
- BLM helicase facilitates telomere replication during leading strand synthesis of telomeres
- (2015) William C. Drosopoulos et al. JOURNAL OF CELL BIOLOGY
- Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity
- (2015) Cheryl M. Koh et al. JOURNAL OF CLINICAL INVESTIGATION
- TERT Promoter Mutations and Risk of Recurrence in Meningioma
- (2015) Felix Sahm et al. JNCI-Journal of the National Cancer Institute
- Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation
- (2015) Yinghui Li et al. NATURE CELL BIOLOGY
- A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
- (2015) Ayalew Tefferi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treating Myeloproliferation — On Target or Off?
- (2015) Mary Armanios et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia
- (2015) Gabriela M. Baerlocher et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Genetic Evolution of Melanoma from Precursor Lesions
- (2015) A. Hunter Shain et al. NEW ENGLAND JOURNAL OF MEDICINE
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
- (2015) R. J. A. Bell et al. SCIENCE
- Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532
- (2015) Christopher Bryan et al. STRUCTURE
- Telomeric G-quadruplexes are a substrate and site of localization for human telomerase
- (2015) Aaron L. Moye et al. Nature Communications
- ATRX represses alternative lengthening of telomeres
- (2015) Christine E. Napier et al. Oncotarget
- ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres
- (2015) Adrian S. Tong et al. Cell Reports
- Cancer-associated TERT promoter mutations abrogate telomerase silencing
- (2015) Kunitoshi Chiba et al. eLife
- TERT Promoter Mutations and Risk of Recurrence in Meningioma
- (2015) Felix Sahm et al. JNCI-Journal of the National Cancer Institute
- Reversibility of Defective Hematopoiesis Caused by Telomere Shortening in Telomerase Knockout Mice
- (2015) Aparna Raval et al. PLoS One
- A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer
- (2014) A. A. Chiappori et al. ANNALS OF ONCOLOGY
- TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
- (2014) Klaus G. Griewank et al. JNCI-Journal of the National Cancer Institute
- Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
- (2014) Gary Middleton et al. LANCET ONCOLOGY
- TCAB1: a potential target for diagnosis and therapy of head and neck carcinomas
- (2014) Chong-kui Sun et al. Molecular Cancer
- Genome-wide analysis of noncoding regulatory mutations in cancer
- (2014) Nils Weinhold et al. NATURE GENETICS
- Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1
- (2014) Roderick J O'Sullivan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes
- (2014) M. Labussiere et al. NEUROLOGY
- Induction of Telomere Dysfunction Mediated by the Telomerase Substrate Precursor 6-Thio-2′-Deoxyguanosine
- (2014) Ilgen Mender et al. Cancer Discovery
- TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
- (2013) I. Kinde et al. CANCER RESEARCH
- A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)
- (2013) P. A. Thompson et al. CLINICAL CANCER RESEARCH
- Inhibition of Telomerase Recruitment and Cancer Cell Death
- (2013) Mai Nakashima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quantitative visualization of DNA G-quadruplex structures in human cells
- (2013) Giulia Biffi et al. Nature Chemistry
- Structure of active dimeric human telomerase
- (2013) Anselm Sauerwald et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Frequency of TERT promoter mutations in human cancers
- (2013) João Vinagre et al. Nature Communications
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Antitelomerase Therapy Provokes ALT and Mitochondrial Adaptive Mechanisms in Cancer
- (2012) Jian Hu et al. CELL
- Telomerase Recruitment Requires both TCAB1 and Cajal Bodies Independently
- (2012) J. L. Stern et al. MOLECULAR AND CELLULAR BIOLOGY
- The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity
- (2012) Jayakrishnan Nandakumar et al. NATURE
- ATM regulates proteasome-dependent subnuclear localization of TRF1, which is important for telomere maintenance
- (2012) M. McKerlie et al. NUCLEIC ACIDS RESEARCH
- Prevalence of the Alternative Lengthening of Telomeres Telomere Maintenance Mechanism in Human Cancer Subtypes
- (2011) Christopher M. Heaphy et al. AMERICAN JOURNAL OF PATHOLOGY
- Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a telomere-independent mechanism
- (2011) E. Nitta et al. BLOOD
- Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes
- (2009) S. Ugel et al. BLOOD
- A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors
- (2009) John Nemunaitis et al. MOLECULAR THERAPY
- A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis
- (2009) A. S. Venteicher et al. SCIENCE
- Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells
- (2008) Ying Cao et al. CANCER SCIENCE
- Targeting the GA Binding Protein 1L Isoform Does Not Perturb Lymphocyte Development and Function
- (2008) H.-H. Xue et al. MOLECULAR AND CELLULAR BIOLOGY
- Structure of the Tribolium castaneum telomerase catalytic subunit TERT
- (2008) Andrew J. Gillis et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started